Thrombolytic Therapy for Acute Pulmonaqy Embolism: Can Mortality Be Decreased?

Moser KM Risk for bleeding in patients with pulmonary embolism treated with thrombolytic agents. Ann Intern Med1995; 122:630.

Palevsky HI , Zukerberg BW , Worsley DF Defining a role for thrombdlytic therapy in the management of pulmonary embolism . J Nucl Med1995;36:369-70.

Anderson FA , Wheeler B. , Goldberg RJ , et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. Arch Intern Med1991; 151:933-8.

Carson JL , Kelley MA , Duff A. , et al. The clinical course of pulmonary embolism. N Engl J Med1992;326:1240-5.

Goldhaber SZ Thrombolysis for pulmonary embolism. Prog Cardiovase Dis1991;34:113-34.

Morganthaler T. , Ryu J. Clinical characteristics of fatal pulmonary embolism in a referred hospital. Mayo Clin Proc1995;70:417-24.

Lau G. Pulmonary thromboembolism is not uncommon-results and implications of a five year study of 116 necropsies. Ann Acad Med Singapore1995;24:356-65.

Stein PD , Henry JW Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest1995; 108:978-81,

Lilienfeld DE , Godbold JH , Burke GL , et al. Hospitalization and case fatality for pulmonary embolism in the twin cities: 1979-1984. Am Heart J1990; 120:392-5.

Soskolne CL , Wong AW , Lilienfeld DE Trends in pulmonary embolism death rates for Canada and the United States, 1962-1987. Can Med Assoc J1990; 142:321-4.

DiRicco G. Marini C. , Rindi M. , et al. Cast Vi embolia pulmonare diagnosticati a Pisa del 1969 al 1984 . G Ital Cardiol1987; 17; 113-9.

Alpert JS , Smith R. , Carlson J. , et al. Mortality in patients treated for pulmonary embolism. JAMA1976:236:1477-80.

Sandler DA , Martin JF Autopsy proven pulmonary embolism in hospital patients; are we detecting enough deep vein thrombosis?J R Soc Med1989 ;82:203-5.

Goldhaber SZ Hennekens CH , Evans DA , et al. Factors associated with correct antemortem diagnosis of major pulmonary embolism. Am J Med1982;73:822-6.

Terrin M. , Goldhaber SZ , Thompson B. Selection of patients with acute pulmonary embolism for thrombolytic therapy . Chest1989; 95:279S.

Maggioni AP , Franzosi MG Santoro E. , et al. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment . N Engl J Med1992 -,327:1-6.

Freiman DC The structure of thrombi. In: Colman RW , Hirsh J , Marder V , Saizman EW , eds. Thrombosis and hemostasis: basic principles and clinical practice, Philadelphia: JB Lippincott, 1982 .

Morpurgo M. , Schmid C. The spectrum of pulmonary embolism: clinicopathologic correlations. Chest1995 ; 107:18S-20S.

American Heart Association. The urokinase pulmonary embolism trial. Circulation1973;4711(suppl):1-100.

Hyers TM , Hull RD ,, Weg JG Antithrombotic therapy for venous thromboembolic disease. Chest1995;108:335S-51S.

Koren G. , Weiss AT , Hasin Y. , et al. Prevention of myocardial damage by early treatment with intravenous streptokinase. N Engl J Med1985;313:384-9.

Gruppo Italiano per lo studio della Streptokinase Nell infarcto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction . Lancet1986; 1:397-402.

ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral as

pirin, both or neither among 17,1 87 cases of suspected acute myocardial infarction . Lancet1998,,'1:545-9.

Parker JA , Drum DE , Feldstein MI , Goldhaber SZ Lung scan evaluation of thrombolytie therapy for pulmonary embolism . J Nucl Med1994;36:364-8.

Goldhaber SZ , Heit J. , Sharma Gvrk , et al. Randomized controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet1988;2:293.

Sors H. , Pacouret G. , Azarian R. , et al. Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. Chest1994 ; 106:712.

Goldhaber SZ , Agnelli G. , Levin MN Reduced dose bolus alteplase vs conventional altephase infusion for pulmonary embolism thrombolysis. Chest1994; 1086:718.

The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med1993;329:673.

Urokinase Streptokinase Pulmonary Embolism Trial. Phase II results. JAMA1974;229:1606-13.

Dalen JE , Alpert JS Natural history of pulmonary embolism. Prog Cardiovase Dis1975;XVII:259-70.

Wolfe MW , Lee RT , Feldstein ML , Parker AJ , Come PC , Goldhaber SZ Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism, Am Heart J1994; 127:1371-5.

Soloff LA , Rodman T. , Acute pulmonary embolism II. Clinical. Am Heart J1967;74:829-47.

Nagel EL , Fine EG , Krischer JP , et al. Complications of CPR. Crit Care Med1981;9:424.

Haugeberg G. , Bonarjee V. , Dickstein K. Fatal intrathoracic hemorrhage after cardiopulmonary resuscitation and treatment with streptokinase and heparin. Br Heart J1989;62:157-8.

Bottiger BW , Bohrer H. , Bach A. , et al. Bolus injection of thrombolytic agents during cardiopulmonary resuscitation for massive pulmonary embolism. Resuscitation1994;28:45-54.

Tenaglia AN , Califf RM , Candela RJ , et al. Thrombolytic therapy in patients requiring cardiopulmonary resuscitation. Am J Cardiot 1991:68:1015-9.

Scholz KH , Tebbe U. , Herrmann C. , et al. Frequency of complications of cardiopulmonary resuscitation after thrombolysis during acute myocardial infarction. Am J Cardiol1992:69:724-8.

Levine M. , Hirsh J. , Weitz J. , et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest1990;98:1473.

Goldhaber SZ , Haire WD , Feldstein ML , et al. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right ventricular function and pulmonary perfusion. Lancet1993 ; 2:293-8.

Tibutt DA , Davies JA , Anderson JA , et al. Comparison by controlled clinical trial of streptokinase and heparin in treatment of life-threatening pulmonary embolism. BMJ1974;1:343.

Dalla-Volta S. , Palla A. , Santolicandro A. , et al. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol1992;20:520.

Come PC , Kim D. , Parker A. , et al. Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with tissue plasminogen activator . Am J Coll Cardiol1987; 10:971-8.